Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway

Qian Li(Shanghai East Hospital), Man Li(Shanghai University of Traditional Chinese Medicine)
International Journal of Biological Sciences
January 1, 2022
Cited by 115


Related Papers